DOI QR코드

DOI QR Code

Whole-Cell Biocatalysis for Producing Ginsenoside Rd from Rb1 Using Lactobacillus rhamnosus GG

  • Ku, Seockmo (Department of Food and Nutrition, Research Institute of Human Ecology, Seoul National University) ;
  • You, Hyun Ju (Department of Food and Nutrition, Research Institute of Human Ecology, Seoul National University) ;
  • Park, Myeong Soo (Department of Hotel Culinary Arts, Yeonsung University) ;
  • Ji, Geun Eog (Department of Food and Nutrition, Research Institute of Human Ecology, Seoul National University)
  • Received : 2016.01.04
  • Accepted : 2016.03.23
  • Published : 2016.07.28

Abstract

Ginsenosides are the major active ingredients in ginseng used for human therapeutic plant medicines. One of the most well-known probiotic bacteria among the various strains on the functional food market is Lactobacillus rhamnosus GG. Biocatalytic methods using probiotic enzymes for producing deglycosylated ginsenosides such as Rd have a growing significance in the functional food industry. The addition of 2% cellobiose (w/v) to glucose-free de Man-Rogosa-Sharpe broths notably induced β-glucosidase production from L. rhamnosus GG. Enzyme production and activity were optimized at a pH, temperature, and cellobiose concentration of 6.0, 40℃, and 2% (w/v), respectively. Under these controlled conditions, β-glucosidase production in L. rhamnosus GG was enhanced by 25-fold. Additionally, whole-cell homogenates showed the highest β-glucosidase activity when compared with disrupted cell suspensions; the cell disruption step significantly decreased the β-glucosidase activity. Based on the optimized enzyme conditions, whole-cell L. rhamnosus GG was successfully used to convert ginsenoside Rb1 into Rd.

Keywords

Introduction

Ginsenosides are primary active components in ginseng roots used for traditional human therapeutic herbal medicines in Asia. Recently, the deglycosylation of ginsenosides before oral ingestion has been a topic of increased interest by the nutraceutical communities [39,40]. These aglycones are regarded as more biologically potent than glycoside forms of ginsenoside [13,30]. Ginsenoside aglycones enter the blood stream more effectively than ginsenoside glycosides and show higher nutraceutical activities when consumed by humans [53].

Among various deglycosylated ginsenosides, ginsenoside Rd (Rd), derived from ginsenosides Rb1, Rb2, and Rb3, has been considered as the primary ginseng quality indicator on the market [30]. Multiple researchers have reported the beneficial effects of Rd for humans (i.e., management of mitochondrial dysfunction [58], anti-obesity [25], wound-healing [27], and immunosuppressive effects [54]). Unlike using chemical (i.e., acid or alkaline) catalysis, the deglycosylation process using bacterial enzymes prevents epimerization, hydration, and hydroxylation [6,7,42].

There are two major approaches to produce microbial enzymes for biocatalytic reactions. One common method is using microorganisms (i.e., E. coli, Flavobacterium) that are genetically modified for high expression of foreign genes and mass production of microbial enzymes [19,34]. However, using enzymes produced from genetically modified (GM) microorganisms has practical limitations when applied directly to the food industry. Without a doubt, E. coli is one of the most well-known, inedible microorganisms for consumers. Flavobacterium is also known to contaminate fresh foods and water [5]. Many food consumers have shown a substantial resistance to GM organisms, with recent reports showing that about 70% of people have a negative response to GM organisms used in their food and about 90% of respondents feel that food products containing GM organisms should be labeled on the package [12,26] . Because of these issues, the addition of GM and/or E. coli ingredients has become a major challenge for industry manufacturers in the world [32,33].

To address this challenge, an alternative method was developed that utilizes probiotic bacteria (i.e., cell-free extracts, intercellular enzymes, whole-cell enzymes). Probiotic bacteria are capable of naturally producing the microbial enzyme; thus, this method is generally recognized as safe (GRAS). Since 1998, the US Food and Drug Administration has provided information for GRAS bacteria types (such as Bifidobacterium spp. and Lactobacillus spp.) [11]. All GRAS microorganisms produce different enzymes with different activities. Therefore, cells and enzymes should be screened to characterize enzyme properties before the treatment of GRAS bacteria for the bioconversion of glycosides. Among the various GRAS bacteria, Lactobacillus rhamnosus GG (LGG) has been widely used in the nutraceutical and dairy industry because of its resistance to acidic environments [9], amenability to food processing [8], and various beneficial effects on humans [15,22]. However, little research has been published on the industrial applications of LGG to the biocatalysis of ginsenosides and/or other phytochemicals.

In our previous work, we reported the enhanced cell recovery and/or enzyme activities for biocatalysis of glycosides using various cultural conditions with modified de Man-Rogosa-Sharpe (MRS) broths [17,29–31,56]. In this study, we report the optimal microbial media composition for production of β-glucosidase from LGG. Then, we characterize the best experimental conditions to produce β-glucosidase for further application of ginsenoside deglycosylation.

 

Materials and Methods

Materials

Panax ginseng was purchased from a local grocery market in Seoul, Korea. Ginsenoside standards Rb2, Rc, and Rd were purchased from BTGin (Korea); Rh1 and Rh2 were from LKT laboratories (USA); and F2 was from Wako Pure Chemical Industries (Japan). Ginseng extracts and Compound K were produced and isolated using the methods of Kim et al. [24]. Chiroinositol and pinitol were kindly donated from Amicogen (Korea). ʟ-Sorbose, ʟ-arabinose, ʟ-rhamnose, lactose, raffinose, myoinositol, mannitol, fructose, glucose, maltose, galactose, sucrose, xylose, cellobiose, ribose, sucralose, mannose, formic acid, and maleic acid were purchased from Samchun Pure Chemical Co., Ltd (Korea). Sucralose, myoinositol, phosphoric acid, lactic acid, glucuronic acid, ascorbic acid, propionic acid, acetic acid, phytic acid, and citric acid were purchased from Sigma (USA). Yeast extract, proteose peptone, and beef extract were purchased from Becton Dickinson(BD) (USA). HPLC-grade acetonitrile, methanol, and water were purchased from J. T. Baker (USA).

Cell Culture Condition

Fifty-one kinds of modified MRS broths containing various dietary sugars, sugar alcohols, and organic acids were prepared according to our previous method (Table 1) [29-31]. Briefly, commercially available MRS medium (Criterion, USA) was used for a control group. Cysteine hydrochloride (0.5% (W/V)) (Sigma, USA) was added into all the broths as a shared oxygen scavenger for the strictly anaerobic media condition. The pH for all culture broths was adjusted to 7.0 ± 0.1 using 1 N sodium hydroxide. Naturally occurring microbiota were removed by microfiltration (0.2 micron, Ersatz–Membrane filter: BRAND, Germany).

Table 1.a2-Deo-glu denotes 2-deoxy-ᴅ-glucose. bCommercially available MRS broth containing 2% (w/v) of glucose as a basal carbon source. cMet-α-ᴅ-gluco denotes methyl-α-ᴅ-glucoside.

In each experiment, the LGG in the frozen stock (–80℃) was activated by streaking on MRS agar followed by anaerobic incubation in fresh MRS + 0.5% (w/v) cysteine hydrochloride at 37℃ for 24 h. The activated cells were inoculated into the 51 kinds of modified MRS broths. After 24 h of cell incubation, the cell pellets were collected by centrifugation at 3,000 ×g for 15 min at 4℃ and then the collected cells were washed twice with phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4 ± 0.1). Cell growth rates were optically measured by a spectrophotometer at 600 nm on a microplate reader (Model Benchmark; Bio-Rad, Japan). The cell growth rates were evaluated by measuring the optical density (OD) and by the plating method.

Enzyme Assay

Cell lysates were prepared after evaluating the cell growth rates from the 52 sample varieties. The cell lysis solution (acetone:toluene = 9:1 (v/v)) was treated into each cell pellet in order to weaken and degrade the cell walls [30,31]. These lysed cell suspensions were applied to analyze the varied enzyme patterns by different microbial culture conditions. The disrupted cell suspensions were produced by a cell sonication process. To evaluate changed enzyme induction patterns, 5 mM p-nitrophenyl-β-ᴅ-glucopyranoside (Sigma, USA) was mixed with 80 μl of lysed LGG suspension collected from each medium and incubated for 30 min at 37℃ [30,31]. The enzyme reaction was stopped with the addition of 100 μl of 0.5 M Na2CO3 solution.

Enzyme Characterization

The standard reaction to investigate the effects of the temperature, pH, physical disruption, and cellobiose concentration in media on the β-glucosidase activity were performed as aforementioned methods [29-31]. The following equation was used for assessing the decreased β-glucosidase activities during the cell disruption process [3,55];

dA/dt = −kA

where A is the enzyme activity of LGG cultured in modified MRS media at time t; k = rate constant; and t = disruption time.

This equation is given by

and hence

or

followed by the simplification of the equation results in

The enhanced LGG enzyme activity by the addition of cellobiose is given by

dA⁄dc = kA

where A is the enzyme activity of LGG cultured in modified MRS media at time t; k = rate constant; and c = level of cellobiose in media.

The decreased β-glucosidase activity by the addition of glucose into the modified MRS is given by

dA⁄dg = –kA

A is an enzyme activity of LGG cultured at modified MRS at time t; k = rate constant; and g = level of glucose in modified MRS.

To determine the optimal concentration of cellobiose, LGG was cultured anaerobically in modified MRS media with 0.5–5% (w/v) of cellobiose at 37℃ for 22 h. To evaluate the effect of the cell disruption, 1 ml (6 × 108 CFU/ml) of the LGG suspension was harvested from the modified MRS medium with 2% (w/v) of cellobiose and washed in ice-cold PBS. The cell pellet was resuspended in 4 ml of PBS and disrupted by cell sonication at 45 amplitude for 30 sec at 4℃. The degree of cell disruption was optically measured at 600 nm. The effect of temperature on the whole-cell β-glucosidase of LGG was investigated at pH 7.4 ± 0.1 at the range of 4℃ to 60℃. Four milliliters of 100 mM acetate buffer (pH 4 and 5) and 100 mM phosphate buffer (pH 6, 7, and 8) were treated to 1 ml (6 × 108 CFU/ml) of the whole LGG suspension in order to investigate the effect of pH.

Ginsenoside Conversion Using Whole LGG Cell

The whole-cell suspensions (6 × 108 CFU/ml) with phosphate buffer (100 mM, pH 6) were mixed with the ginseng extracts at the ratio of 19:1 (v/v) and incubated at 40℃. The cell-ginseng extract suspensions were collected after 2 and 4 days. TLC analysis was performed to evaluate the bioconversion of ginsenosides [30,31].

Statistical Analysis

All research data were the average of triplicate tests. Significant differences were evaluated by t-tests using Microsoft Excel 2013 and analysis of variance with the help of Minitab 16 followed by post hoc comparisons using Tukey’s test. Differences at p < 0.05 were considered to be statistically significant [30].

 

Results and Discussions

LGG Growth in Modified MRS Media

Conventional MRS medium has been commonly recommended for use in the cultivation of lactic acid bacteria (e.g., Bifidobacterium spp., Lactobacillus spp.) in industry [10]. Based on the ratio of MRS medium compositions, 51 types of modified MRS media containing 4% (w/v) of different carbons, acids, and other chemicals were tested (Table 1). In order to check the effect of specific nutrients on LGG growth, we added 4% (w/v) of different nutrients to glucose-free MRS medium (See Table 1; #1–20) and 2% (w/v) sources into the conventional MRS medium, which originally contained 2% (w/v) glucose as a basal carbon source (media #21–51). Commercially available MRS medium was used for a control group (medium #52). As a single carbohydrate, ʟ-sorbose, ʟ-arabionose, ʟ-rhamnose, lactose, raffinose, myoinositol, chiroinositol, pinitol, maltose, sucrose, xylose, 2-deoxy-ᴅ-glucose, ribose, and sucralose (media #1–8, 12, 14–16, 18, and 19) instead of glucose was ineffective for the growth of LGG (p < 0.05) (Fig. 1). The growth rate of LGG cultured in the modified MRS medium containing 4% (w/v) cellobiose (medium # 17) did not have statistically significant differences from the control group (p > 0.05). In our previous work, ascorbic acid and phytic acid induced significant morphological changes and/or enzyme activities from Bifidobacterium spp. [29,30]. Accordingly, multiple organic acids were also added into the media to evaluate their effects on cell growth. However, the addition of 2% (w/v) glucuronic acid, formic acid, and maleic acid to commercial MRS medium exhibited statistically significant growth inhibiting effects on LGG (p < 0.05).

Fig. 1.Relative growth rates of L. rhamnosus GG cultured in the various broths (n = 3). Commercially available MRS medium (black bar:■) was used as a control group. Media #17 (white bar:□) and #37 (upward diagonal bar:) are glucose-free MRS medium containing 4% (w/v) of cellobiose and normal MRS medium containing 2% (w/v) of cellobiose, respectively.

Multiple researchers previously reported that LGG was unable to decompose certain carbon sources (i.e., sucrose [36], lactose [38,44] rhamnose, ribose, maltose [23], ʟ-sorbose, xylose, methyl-α-ᴅ-glucoside [44], arabinose, and raffinose [18,44]). However, in contrast to the report from Balejko et al. [4], LGG successfully fermented fructose (media #10 and 30) as a carbon source. LGG also used mannitol (medium #9), glucose (media #11, 31, and 52), galactose (media #13 and 33), cellobiose (media #17 and 37), and mannose (media #20 and 40) as carbon sources and the results of this work are in accord with Saxelin [44].

Role of Cellobiose

Among the various carbon sources, glucose is the primary carbon source from which general chemoheterotrophic organisms can produce energy and provide enriched nutrients and act as metabolic precursors for cell growth [9]. Generally, the addition of glucose to microbial broth increases cell growth rates and cell biomass yield. If high cell recovery is the major goal, then the use of glucose is advantageous for industrial purposes. On the other hand, if the major goal is enzyme recovery or induction of glycolytic enzymes, then glucose is one of the major inhibitory reagents for that purpose when the concentration is too high [52]. Multiple studies have shown that the presence of high levels of glucose or certain carbon sources in the media can significantly decrease enzyme activities in microorganisms [14,16]. Increased concentrations of glucose or other sugar supplements have shown decreased microbial enzyme activities.

In our study, the glucose-free MRS containing 4% (w/v) cellobiose was the most fertile medium for the induction of β-glucosidase from LGG (See Fig. 2; medium #17). β-glucosidase activity was increased markedly with the addition of cellobiose into the medium, rather than glucose. This indicates that β-glucosidase is undoubtedly an inducible enzyme. For further examination of the effect of cellobiose, 0–5% (w/v) of cellobiose was added to glucose-free MRS broth (Fig. 3). As a result, the degree of enzyme activity increased significantly as the concentration of cellobiose increased up to 2% (p < 0.05). There were no statistically significant differences across the four samples containing 2% to 5% (w/v) of cellobiose (p > 0.05). Additional cellobiose treatment into the media did not enhance enzyme activity and cell growth rates. However, the addition of glucose into the modified MRS broth containing 2% (w/v) of cellobiose instead of glucose notably decreased enzyme induction (p < 0.05) (Fig. 4).

Fig. 2.Relative β-glucosidase activities of L. rhamnosus GG cultured in the various broths (n = 3). Cell lysis solution was treated to samples to degrade cell walls. Black bar (■) denotes commercially available MRS medium. Media #17 (white bar:□) and #37 (upward diagonal bar:) are glucose-free MRS medium containing 4% (w/v) of cellobiose and normal MRS medium containing 2% (w/v) of cellobiose, respectively.

Fig. 3.Effect of cellobiose on the production of β-glucosidase (triangles) from L. rhamnosus GG (n = 3). Cell lysis solution was treated to samples. Bar graphs denote cell growth rates. Error bars represent standard deviation. The solid line represents changed enzyme activities. The dotted line represents the intercept from 0 to 2% (w/v) of cellobiose groups. Commercially available MRS broth (Criteron, USA) was used as a control group.

Fig. 4.Effect of glucose on the induction of β-glucosidase (triangles) from L. rhamnosus GG (n = 3). Cell lysis solution was treated to samples. Bar graphs denote cell growth rates. Error bars represent standard deviation. The solid line represents changed enzyme activities. The dotted line represents the intercept from 0 to 2% (w/v) of glucose groups. Commercially available MRS broth (Criteron, USA) was used as a control group.

Media components act as substrates or substrate analogs for microbial enzymes, and these function as enzyme inducers [49]. When polysaccharides or disaccharides are used as carbon sources, probiotic bacteria have shown a tendency to hydrolyze their glycosidic bonds to take glucose for their energy source [43]. Therefore, introducing these strictly glucose-limited conditions to bacteria is a prerequisite to studying microbial enzyme physiology under such controlled conditions. Despite the routines of using MRS medium for the cultivation of probiotic bacteria, including Lactobacillus and Bifidobacterium, MRS medium is not an essential medium for the production of microbial enzymes because it only contains glucose as a carbon source. The medium composition-dependent induction of microbial enzymes has significant implications. As our previous data clearly showed, each medium supplement (i.e., galactose, phytic acid, ascorbic acid) was used to induce different enzymes and metabolic compounds, thereby confirming a relationship exists between glycosidic enzymes and the composition of the medium [29–31]. Therefore, the use of MRS broth in enzyme induction, particularly without gene work, is limited. It was further confirmed that medium composition significantly affects enzyme induction levels and glucose acts an as inhibitor of β-glucosidase production (Fig. 4). We suggest that ongoing medium development should be carried out as a routine process for the production of microbial enzymes that can later be employed for the bioconversion of phytochemicals.

Optimal Conditions for β-Glucosidase

In terms of an optimal condition for enzyme hydrolysis, pH and temperature are key factors. Moreover, optimal β-glucosidase conditions may vary according to the host cell. Unlike a normal assay, without using a cell disruption process, we directly applied a whole-cell suspension to evaluate the optimal condition of β-glucosidase owing to its distinctive enzyme characteristics. In Figs. 5 and 6, β-glucosidase activity from Lactobacillus rhamnosus GG was evaluated at different pH and temperatures in the range of 4 to 8 and 4℃ to 60℃, using p-nitrophenyl-β-ᴅ-glucopyranoside as a substance. The enzyme activity reached a maximum value at pH 6 and 40℃. There are various reports that related how β-glucosidases produced from multiple probiotic bacteria express their maximum enzyme activity at somewhat acidic conditions [35,37,46]. The whole-cell suspension of Lactobacillus rhamnosus NRRL 442 showed the highest β-glucosidase activity at pH 6.5 [28].

Fig. 5.Effect of pH on the whole-cell β-glucosidase of L. rhamnosus GG cultured in normal MRS (black) and modified MRS (white) media (n = 3) at 37℃. For the experiments, cell lysis or disruption process was not applied. Bars with *** represent statistically significant differences between groups at p < 0.001.

Fig. 6.Relative β-glucosidase activity of whole-cell L. rhamnosus GG from normal MRS (black) and modified MRS (white) media (n = 3) at various temperatures at pH 5.0. For the experiments, cell lysis or disruption processes were not applied. Bars with *** represent statistically significant differences between groups at p < 0.001.

Whole-Cell Biocatalyst

The β-glucosidase of LGG was evaluated as a whole-cell fraction and a disrupted cell fraction (Fig. 7). Cell activity in the whole-cell fraction was highest; however, the degree of β-glucosidase was proportionally decreased over the cell disruption step with approximately 10% of total activity. The remaining β-glucosidase activity in the disrupted cell suspension was approximately 10% of the activity. Without the cell disruption process, the whole-cell suspension efficiently hydrolyzed p-nitrophenyl-β-ᴅ-glucopyranoside. These results indicate that β-glucosidase apparently exists in a cell-wall-associated structure and is not resistant to physical disruption since in the strains examined in this work, the enzyme activity in the whole-cell suspension was always higher than β-glucosidase measured in the lysed or disrupted cell suspensions and cell-free extracts (data not shown). Relevant glycosidase activities have also been reported for the Lactobacillus delbrueckii mutant Uc-3 [2] and Lactobacillus lactis mutant RM2-24 [47] responsible for cellobiose, cellotriose, and cellulose fermentation. In their work, the β-glucosidase activity in a disrupted cell was lower than those of the whole cells. No activities were detected in the supernatant, suggesting that these activities are cell wall/membrane bound. Their experimental design and results are similar to the findings presented in this work.

Fig. 7.The decreased β-glucosidase activities (triangles) and OD values (circles) as a function of sonication time at pH 5.0 (n = 3). The solid and dotted lines denote intercepts of OD values and enzyme activities. Error bars represent standard deviation.

According to Schüürmann et al. [45], when using whole-cell biocatalysts and cell cytosolic enzymes, it is necessary for target substrates and products to be able to enter the outer membrane barrier effectively. Multiple cell ingredients and metabolites can inhibit the desired reaction. Using the whole cell in the production of pharmaceutical compounds or intermediates is therefore a restriction for this particular phenomenon. Therefore, multiple researchers have used cell disruption and centrifugation processes to produce cell-free extracts or cytosolic enzyme solutions for ginsenoside biocatalysis [7,57]. Enzymes containing these extracts are able to effectively access target substrates and demonstrate reaction-rate limited kinetics [48]. However, a whole-cell biocatalyst with surface-displayed enzymes is able to overcome the restrictions generated by physical barriers [45]. According to Prather [41], there are several advantages of using a whole-cell catalyst for substrate conversion (Table 2). The use of whole-cell bacteria as an enzyme for biocatalytic process avoids the more time-consuming and laborious processes of enzyme production, purification, and perhaps increased production costs [50].

Table 2.Adapted and modified from Prather [41].

Bioconversion of Ginsenoside Rb1

Multiple researchers have reported the effect and function of cell surface-displayed enzymes (i.e., β-glucanase [21], xylanase [20], and lipase [51]). However, these works have not been practically applied with commercially relevant products and industrial application [45]. For industrial purposes, we used this whole-cell catalysis ability for ginsenoside conversion. After LGG was cultured in modified MRS medium with 2% (w/v) cellobiose, the whole-cell suspension (pH 6 and 40℃) was used for biocatalyst of ginsenoside Rb1 into Rd as shown in Fig. 8. The TLC shows that ginsenoside Rb1 was successfully converted by the whole-cell suspension. Multiple researchers have reported the gene expression of surface display enzymes for the purpose of application to carbohydrate degradation [1,50]. However, the practical applications of these strategies in the food industry may be difficult owing to their use of GM organisms. In summary, the high correlation coefficient suggests that the level of the cellobiose and glucose have a significant impact on enzyme production. The addition of cellobiose into the culture media (rather than glucose) can be used for β-glucosidase production from LGG. The β-glucosidase activity is notably decreased by the cell disruption process and with the addition of glucose to the media. The whole-cell β-glucosidase has been applied for converting ginsenoside Rb1 into Rd without the use of gene work and enzyme purification processes (i.e., cell disruption, centrifugation to produce cell-free extracts or purified enzyme). To our best knowledge, this is the first study with the aim to investigate the properties of whole-cell β-glucosidase from LGG and its use for ginsenoside conversion.

Fig. 8.TLC analysis of β-glucosidase conversion of ginsenoside Rb1 into Rd by whole-cell L. rhamnosus GG. Analysis was carried out under optimized conditions: addition of 2% cellobiose into glucose-free MRS broth; restriction of additional glucose supplements during cell growth; maintaining the pH and temperature of 6.0 and 40℃, respectively; and no cell disruption step for optimal enzyme activity.

References

  1. Adachi N, Takahashi C, Ono-Murota N, Yamaguchi R, Tanaka T, Kondo A. 2013. Direct ʟ-lysine production from cellobiose by Corynebacterium glutamicum displaying beta-glucosidase on its cell surface. Appl. Microbiol. Biotechnol. 97: 7165-7172. https://doi.org/10.1007/s00253-013-5009-4
  2. Adsul M, Khire J, Bastawde K, Gokhale D. 2007. Production of lactic acid from cellobiose and cellotriose by Lactobacillus delbrueckii mutant Uc-3. Appl. Environ. Microbiol. 73: 5055-5057. https://doi.org/10.1128/AEM.00774-07
  3. Atkinson AJ, Abernethy DR, Daniel CE, Dedrick RL, Markey SP. 2007. Principles of Clinical Pharmacology, pp. 18-20. 2nd Ed. Elsevier Inc., Burlington, MA.
  4. Balejko E, Kucharska E, Balejko J. 2012. Influence of Lactobacillus rhamnosus gg methabolites on growth of periodontal diseases bacteria. Electron. J. Polish Agric. Univ. 15: 1-7.
  5. Berdanier CD, Dwyer JT, Feldman EB. 2007. Handbook of Nutrition and Food, pp. 20-21. 3rd Ed. Taylor & Francis CRC Press, Boca Raton, FL.
  6. Chen Y, Nose M, Ogihara Y. 1987. Alkaline cleavage of ginsenoside. Chem. Pharm. Bull. (Tokyo) 35: 1653-1655. https://doi.org/10.1248/cpb.35.1653
  7. Chi H, Ji GE. 2005. Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms. Biotechnol. Lett. 27: 765-771. https://doi.org/10.1007/s10529-005-5632-y
  8. Corcoran BM, Ross RP, Fitzgerald GF, Stanton C. 2004. Comparative survival of probiotic lactobacilli spray-dried in the presence of prebiotic substances. J. Appl. Microbiol. 96: 1024-1039. https://doi.org/10.1111/j.1365-2672.2004.02219.x
  9. Corcoran BM, Stanton C, Fitzgerald GF, Ross RP. 2005. Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Appl. Environ. Microbiol. 71: 3060-3067. https://doi.org/10.1128/AEM.71.6.3060-3067.2005
  10. Difco. https://www.bd.com/europe/regulatory/Assets/IFU/Difco_BBL/288110.pdf. Accessed Dec. 20, 2015.
  11. FDA. 2015. http://www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices&sort=Substance&order=ASC&search=. Accessed Dec. 20, 2015.
  12. Food Safety and Sustainability Center. 2014. http://www.greenerchoices.org/pdf/cr_fsasc_gmo_final_report_10062014.pdf. Accessed Dec. 17, 2015.
  13. Gao F, Zhang JM, Wang ZlG, Peng W, Hu HL, Fu CM. 2013. Biotransformation, a promising technology for anti-cancer drug development. Asian Pac. J. Cancer Prev. 14: 5599-5608. https://doi.org/10.7314/APJCP.2013.14.10.5599
  14. Gielkens M, González-Candelas L, Sánchez-Torres P, van de Vondervoort P, de GraaV L, Visser J, Ramón D. 1999. The abfB gene encoding the major a-ʟ-arabinofuranosidase of Aspergillus nidulans: nucleotide sequence, regulation and construction of a disrupted strain. Microbiology 145: 735-741. https://doi.org/10.1099/13500872-145-3-735
  15. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. 1992. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci 37: 121-128. https://doi.org/10.1007/BF01308354
  16. Gueimonde M, Noriega L, Margolles A, Reyes-Gavilán CG. 2007. Induction of a-ʟ-arabinofuranosidase activity by monomeric carbohydrates in Bifidobacterium longum and ubiquity of encoding genes. Arch. Microbiol. 187: 145-153. https://doi.org/10.1007/s00203-006-0181-x
  17. Han YR, Youn SY, Ji GE, Park MS. 2014. Production of α-and β-galactosidases from Bifidobacterium longum subsp. longum RD47. J. Microbiol. Biotechnol. 24: 675-682. https://doi.org/10.4014/jmb.1402.02037
  18. Hedberg M, Hasslöf P, Sjöström I, Twetman S, Stecksén-Blicks C. 2008. Sugar fermentation in probiotic bacteria - an in vitro study. Oral Microbiol. Immunol. 23: 482-485. https://doi.org/10.1111/j.1399-302X.2008.00457.x
  19. Hong H, Cui CH, Kim JK, Jin FX, Kim SC, Im WT. 2012. Enzymatic biotransformation of ginsenoside Rb1 and gypenoside XVII into ginsenosides Rd and F2 by recombinant β-glucosidase from Flavobacterium johnsoniae. J. Ginseng Res. 36: 418-424. https://doi.org/10.5142/jgr.2012.36.4.418
  20. Hsueh HY, Yu B, Liu CT, Liu JR. 2014. Increase of the adhesion ability and display of a rumen fungal xylanase on the cell surface of Lactobacillus casei by using a listerial cell-wall-anchoring protein. J. Sci. Food Agric. 94: 576-584. https://doi.org/10.1002/jsfa.6298
  21. Huang SJ, Chen MJ, Yueh PY, Yu B, Zhao X, Liu JR. 2011. Display of Fibrobacter succinogenes β-glucanase on the cell surface of Lactobacillus reuteri. J. Agric. Food Chem. 59: 1744-1751. https://doi.org/10.1021/jf104266x
  22. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. 1991. A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88: 90-97.
  23. Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, et al. 2009. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc. Natl. Acad. Sci. USA 40: 17193-171938. https://doi.org/10.1073/pnas.0908876106
  24. Kim MS, Kwon B, Park MS, Ji GE. 2008. Isolation of ginsenoside Rh1 and compound K from fermented ginseng and efficacy assessment on systemic anaphylactic shock. Food Sci. Biotechnol. 17: 805-808.
  25. Kim MS, Lee MS, Kim SH, Kim HJ, Sung MJ, Kim HY, et al. 2007. Anti-obesity effects of ginsenoside Rd via AMPK and PPAR gamma. Korean J. Biotechnol. Bioeng. 22: 341-344.
  26. Kim RB. 2012. Consumer attitude of risk and benefits toward genetically modified (GM) foods in South Korea: implications for food policy. Eng. Econ. 23: 189-199. https://doi.org/10.5755/j01.ee.23.2.1548
  27. Kim WK, Song SY, Oh WK, Kaewsuwan S, Tran TL, Kim WS, Sung JH. 2013. Wound-healing effect of ginsenoside Rd from leaves of Panax ginseng via cyclic AMP-dependent protein kinase pathway. Eur. J. Pharmacol. 702: 285-293. https://doi.org/10.1016/j.ejphar.2013.01.048
  28. Kok FS, Muhamad II, Lee CT, Razali F, Pa’e N, Shaharuddin S. 2012. Effects of pH and temperature on the growth and β-glucosidase activity of Lactobacillus rhamnosus NRRL 442 in anaerobic fermentation. Int. Rev. Biophys. Chem. (IREBIC) 3: 24-30.
  29. Ku S, You HJ, Ji GE. 2009. Enhancement of anti-tumorigenic polysaccharide production, adhesion, and branch formation of Bifidobacterium bifidum BGN4 by phytic acid. Food Sci. Biotechnol.18: 749-754.
  30. Ku S, You HJ, Park MS, Ji GE. 2015. Effects of ascorbic acid on α-ʟ-arabinofuranosidase and α-ʟ-arabinopyranosidase activities from Bifidobacterium longum RD47 and its application to whole cell bioconversion of ginsenoside. J. Korean Soc. Appl. Biol. Chem. 58: 857-865. https://doi.org/10.1007/s13765-015-0113-z
  31. Ku S, Zheng H, Park MS, Ji GE. 2011. Optimization of β-glucuronidase activity from Lactobacillus delbrueckii Rh2 and its use for biotransformation of baicalin and wogonoside. J. Korean Soc. Appl. Biol. Chem. 54: 275-280. https://doi.org/10.3839/jksabc.2011.043
  32. Library of Congress. 2015. http://www.loc.gov/law/help/restrictions-on-gmos/eu.php#Opinion. Accessed Dec. 16, 2015.
  33. Library of Congress. 2015. http://www.loc.gov/law/help/restrictions-ongmos/usa.php#Foodstuffs. Accessed Dec. 28, 2015.
  34. Ma MF, Li SJ, Jin FX, Yu HS. 2012. Expression of ginsenoside glucosidase gene in E. coli and renaturation of inclusion body. J. Dalian Polytechnic Univ. 1: 004.
  35. Matsuura M, Sasaki J, Murao S. 1995. Studies on β-glucosidases from soybeans that hydrolyze daidzin and genistin: isolation and characterization of an isozyme. Biosci. Biotechnol. Biochem. 59: 1623-1627. https://doi.org/10.1271/bbb.59.1623
  36. Meurman JH, Antila H, Korhonen A, Salminen S. 1995. Effect of Lactobacillus rhamnosus strain GG (ATCC 53103) on the growth of Streptococcus sobrinus in vitro. Eur. J. Oral Sci. 103: 253-258. https://doi.org/10.1111/j.1600-0722.1995.tb00169.x
  37. Michlmayr H, Schümann C, Barreira Braz da Silva NM, Kulbe KD, Del Hierro AM. 2010. Isolation and basic characterization of a β-glucosidase from a strain of Lactobacillus brevis isolated from a malolactic starter culture. J. Appl. Microbiol. 108: 550-559. https://doi.org/10.1111/j.1365-2672.2009.04461.x
  38. Näse L, Hatakka K, Savilahti E, Saxelin M, Pönkä A, Poussa T, et al. 2001. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 35: 412-420. https://doi.org/10.1159/000047484
  39. Park CS, Yoo MH, Noh KH, Oh DK. 2012. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl. Environ. Microbiol. 87: 9-19.
  40. Park SJ, Youn SY, Ji GE, Park MS. 2012. Whole cell biotransformation of major ginsenosides using leuconostocs and lactobacilli. Food Sci. Biotechnol. 21: 839-844. https://doi.org/10.1007/s10068-012-0108-z
  41. Prather K. 2004. http://www.myoops.org/cocw/mit/NR/rdonlyres/Chemical-Engineering/10-492-2Fall-2004/684CA372-551B-4E59-88F1-4E338646E58A/0/lecture5.pdf. Accessed Dec. 17, 2015.
  42. Quan K, Liu Q, Wan JY, Zhao YJ, Guo RZ, Alolga RN, et al. 2015. Rapid preparation of rare ginsenosides by acid transformation and their structure-activity relationships against cancer cells. Sci. Rep. 5: 8598. https://doi.org/10.1038/srep08598
  43. Sanchez S, Demain, AL. 2008. Metabolic regulation and overproduction of primary metabolites. Microb. Biotechnol. 1: 283-319. https://doi.org/10.1111/j.1751-7915.2007.00015.x
  44. Saxelin M. 1997. Lactobacillus GG: a human probiotic strain with thorough clinical documentation. Food Rev. Int. 13: 293-313. https://doi.org/10.1080/87559129709541107
  45. Schüürmann J, Quehl P, Festel G, Jose J. 2014. Bacterial whole-cell biocatalysts by surface display of enzymes: toward industrial application. Appl. Microbiol. Biotechnol. 98: 8031-8046. https://doi.org/10.1007/s00253-014-5897-y
  46. Sestelo ABF, Poza M, Villa TG. 2004. β-Glucosidase activity in a Lactobacillus plantarum wine strain. World J. Microbiol. Biotechnol. 20: 633-637. https://doi.org/10.1023/B:WIBI.0000043195.80695.17
  47. Singhvi M, Joshi D, Adsul M, Varma A, Gokhale D. 2010. ᴅ-(−)-Lactic acid production from cellobiose and cellulose by Lactobacillus lactis mutant RM2-24. Green Chem. 12: 1106-1109. https://doi.org/10.1039/b925975a
  48. Smith MR, Khera E, Wen F. 2015. Engineering novel and improved biocatalysts by cell surface display. Ind. Eng. Chem. Res. 54: 4021-4032. https://doi.org/10.1021/ie504071f
  49. Stanbury PF, Whitaker A, Hall SJ. 1995. Principles of Fermentation Technology, pp. 106, 2nd Edn. Elsevier Science Inc., Burlington, MA.
  50. Tateno T, Fukuda H, Kondo A. 2007. Production of ʟ-lysine from starch by Corynebacterium glutamicum displaying α-amylase on its cell surface. Appl. Microbiol. Biotechnol. 74: 1213-1220. https://doi.org/10.1007/s00253-006-0766-y
  51. Tsuchiya A, Kobayashi G, Yamamoto H, Sekiguchi J. 1999. Production of a recombinant lipase artificially localized on the Bacillus subtilis cell surface. FEMS Microbiol. Lett. 176: 373-378. https://doi.org/10.1111/j.1574-6968.1999.tb13686.x
  52. van der Veen P, Arst HN Jr, Flipphi MJ, Visser J. 1994. Extracellular arabinases in Aspergillus nidulans: the effect of different cre mutations on enzyme levels. Arch. Microbiol. 162: 433-440. https://doi.org/10.1007/BF00282109
  53. Wakabayashi C, Hasegawa H, Murata J, Saiki I. 1997. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol. Res. 9: 411-417.
  54. Wang L, Zhang Y, Chen J, Li S, Wang Y, Hu, L, et al. 2012. Immunosuppressive effects of ginsenoside-Rd on skin allograft rejection in rats. J. Surg. Res. 176: 267-274. https://doi.org/10.1016/j.jss.2011.06.038
  55. Ximenes E, Kim Y, Mosier N, Dien B, Ladisch MR. 2011. Deactivation of cellulases by phenols. Enzyme Microb. Technol. 48: 54-60. https://doi.org/10.1016/j.enzmictec.2010.09.006
  56. Xu C, Ji GE. 2013. Bioconversion of flavones during fermentation in milk containing Scutellaria baicalensis extract by Lactobacillus brevis. J. Microbiol. Biotechnol. 23: 1422-1427. https://doi.org/10.4014/jmb.1305.05001
  57. Yan Q, Zhou XW, Zhou W, Li XW, Feng MQ, Zhou P. 2008. Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces Bainier. J. Microbiol. Biotechnol. 18: 1081-1089.
  58. Zhou JS, Wang JF, He BR, Cui YS, Fang XY, Ni JL, et al. 2014. Ginsenoside Rd attenuates mitochondrial permeability transition and cytochrome c release in isolated spinal cord mitochondria: involvement of kinase-mediated pathways. Int. J. Mol. Sci. 15: 9859-9877. https://doi.org/10.3390/ijms15069859

Cited by

  1. Finding and Producing Probiotic Glycosylases for the Biocatalysis of Ginsenosides: A Mini Review vol.21, pp.5, 2016, https://doi.org/10.3390/molecules21050645
  2. Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism vol.17, pp.9, 2016, https://doi.org/10.3390/ijms17091544
  3. Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products vol.26, pp.5, 2016, https://doi.org/10.1007/s10068-017-0159-2
  4. Efficient (3R)-Acetoin Production from meso-2,3-Butanediol Using a New Whole-Cell Biocatalyst with Co-Expression of meso-2,3-Butanediol Dehydrogenase, NADH Oxidase, and Vitreoscilla Hemoglobin vol.27, pp.1, 2016, https://doi.org/10.4014/jmb.1608.08063
  5. Bioconversion Using Lactic Acid Bacteria: Ginsenosides, GABA, and Phenolic Compounds vol.27, pp.5, 2016, https://doi.org/10.4014/jmb.1612.12005
  6. Acceleration of Aglycone Isoflavone and γ-Aminobutyric Acid Production from Doenjang Using Whole-Cell Biocatalysis Accompanied by Protease Treatment vol.27, pp.11, 2017, https://doi.org/10.4014/jmb.1705.05052
  7. Enhancement of active compound, genipin, from Gardeniae Fructus using immobilized glycosyl hydrolase family 3 β-glucosidase from Lactobacillus antri vol.7, pp.1, 2017, https://doi.org/10.1186/s13568-017-0360-y
  8. Bacillus Cellulase Molecular Cloning, Expression, and Surface Display on the Outer Membrane of Escherichia coli vol.23, pp.2, 2016, https://doi.org/10.3390/molecules23020503
  9. Use of Lactobacillus rhamnosus (ATCC 53103) as Whole-Cell Biocatalyst for the Regio- and Stereoselective Hydration of Oleic, Linoleic, and Linolenic Acid vol.8, pp.3, 2016, https://doi.org/10.3390/catal8030109
  10. Anti-Obesity Effects of a Mixture of Fermented Ginseng, Bifidobacterium longum BORI, and Lactobacillus paracasei CH88 in High-Fat Diet-Fed Mice vol.28, pp.5, 2016, https://doi.org/10.4014/jmb.1801.01016
  11. Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin vol.6, pp.2, 2016, https://doi.org/10.3390/biomedicines6020039
  12. Biocatalysis of Platycoside E and Platycodin D3 Using Fungal Extracellular β-Glucosidase Responsible for Rapid Platycodin D Production vol.19, pp.9, 2016, https://doi.org/10.3390/ijms19092671
  13. Production of Selenomethionine-Enriched Bifidobacterium bifidum BGN4 via Sodium Selenite Biocatalysis vol.23, pp.11, 2016, https://doi.org/10.3390/molecules23112860
  14. Enhancing Immunomodulatory Function of Red Ginseng Through Fermentation Using Bifidobacterium animalis Subsp. lactis LT 19-2 vol.11, pp.7, 2019, https://doi.org/10.3390/nu11071481
  15. Isolation and characterization of high exopolysaccharide-producing Weissella confusa VP30 from young children’s feces vol.18, pp.None, 2016, https://doi.org/10.1186/s12934-019-1158-1
  16. Microbial biocatalysis of quercetin-3-glucoside and isorhamnetin-3-glucoside inSalicornia herbaceaand their contribution to improved anti-inflammatory activity vol.10, pp.9, 2016, https://doi.org/10.1039/c9ra08059g
  17. Biocatalytic strategies for the production of ginsenosides using glycosidase: current state and perspectives vol.104, pp.9, 2016, https://doi.org/10.1007/s00253-020-10455-9